GlassScriptPhysician profile
Brandon Hammond
NPI 1902339427
$5,205.55
in general payments reported to CMS, 2019-2025
45 companies · $924 in 2025
The $924 reported for 2025 was more than what 85% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $423 · 2021: $803 · 2022: $701 · 2023: $847 · 2024: $1,507 · 2025: $924.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,278.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,278.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,451.22 | 2021-2025 | |
| Novo Nordisk INC | $443.34 | 2020-2025 | Wegovy, Ozempic, Rybelsus |
| Astrazeneca Pharmaceuticals LP | $389.75 | 2021-2025 | Farxiga, Airsupra |
| Corium, LLC | $324.49 | 2022-2024 | Azstarys |
| Glaxosmithkline, LLC. | $296.03 | 2021-2024 | Trelegy Ellipta, Arexvy, Shingrix |
| Takeda Pharmaceuticals U.S.A., INC. | $254.00 | 2020-2024 | Trintellix |
| Lilly USA, LLC | $221.88 | 2021-2025 | Mounjaro, Zepbound |
| Abbott Laboratories | $142.89 | 2024-2025 | Freestyle Libre 3 |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $130.05 | 2020-2024 | Xifaxan, Trulance |
| Pfizer INC. | $124.94 | 2024-2025 | |
| Otsuka America Pharmaceutical, INC. | $117.86 | 2022-2025 | Rexulti |
| Merck Sharp & Dohme LLC | $101.01 | 2020-2021 | |
| Allergan, INC. | $71.79 | 2020 | |
| Exact Sciences Corporation | $68.03 | 2024-2025 | Cologuard Collection Kit |
| Ironshore Pharmaceuticals INC. | $66.51 | 2023-2024 | Jornay Pm |
Show all 45 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brandon Hammond listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.